A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2001
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408036A1 Combination of growth hormone secretagogues and antidepressants
11/29/2001	CA2407784A1 Treatment of acute coronary syndrome with glp-1
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158046A1 Superoxide Dismutase-4
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157987A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
11/28/2001	EP1157705A2 Use of a phosphodiesterase inhibitor in the manufacture of a medicament for blood pressure stabilization during hemodialysis
11/28/2001	EP1157695A1 Method of treating obesity using a neurotensin receptor ligand
11/28/2001	EP1157275A1 Novel transduction molecules and methods for using same
11/28/2001	EP1157108A1 Methods and reagents for inhibiting proliferation of smooth muscle cells
11/28/2001	EP1157104A2 Pyk2 binding proteins
11/28/2001	EP1157076A1 Radioactive coating solutions, methods, and substrates
11/28/2001	EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157003A1 Acylated aminoacetonitriles as cysteine protease inhibitors
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP1156999A1 Method for the preparation of a chiral-beta-amino ester
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD
11/28/2001	EP1156798A1 Felbamate derived compounds
11/28/2001	EP1156794A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen
11/28/2001	EP1156759A1 Biodegradable polymeriprotein based coils for intralumenal implants
11/28/2001	EP0983068B1 THE USE OF 1,2,4-TRIAZOLO 1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
11/28/2001	EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
11/28/2001	EP0830344B1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors
11/28/2001	EP0817622B1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0783503B1 2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives
11/28/2001	EP0678027B1 Anti-atherosclerotic agents
11/28/2001	EP0677051B1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
11/28/2001	EP0673368B1 Novel nicotinic acid esters
11/28/2001	EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324394A Method for extracting lipid from marine and aquatic animal tissues
11/28/2001	CN1324367A Cyclic prosaposin-derived peptides and uses thereof
11/28/2001	CN1324364A Phosphoglycolipid and methods for its use
11/28/2001	CN1324360A Bicyclic nitrogen heterocycles
11/28/2001	CN1324359A Tricyclic carboxamides
11/28/2001	CN1324358A Imidazo [4,5-C-] pyridine-4-one derivatives with factor XA inhibiting effect
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1324251A Method of stimulating prosaposin receptor activity
11/28/2001	CN1324242A Novel NEUROPILIN/growth factor binding and use thereof
11/28/2001	CN1323800A Pseudo gensenoside-Pgq and its semi-synthesis and medicinal use
11/28/2001	CN1323631A Paralysis treating medicine bolus
11/28/2001	CN1323608A Xinnaotong capsule for treating blood vessel of heart and brain
11/28/2001	CN1323607A Fast-acting heart disease curing drop pill
11/28/2001	CN1323602A Piles treating medicine and its prepn.
11/28/2001	CN1323583A Medicinal use of beta-ecdysterone
11/28/2001	CN1323582A Prepn. of injecta powder containing tannic acid component
11/28/2001	CN1075385C Medicine for treatment of piles and prepn. method thereof
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323226 Preventing congestive heart failure with cyclooxygenase enzyme
11/27/2001	US6323217 Cardiovascular disorders
11/27/2001	US6323214 Allosteric adenosine receptor modulators
11/27/2001	US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001	US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001	US6323204 Analgesics, antiinflammatory agents and antiischemic agents
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323197 Non-competitive inhibiting of the ampa receptors, these compounds can be used as medicaments for treatment of the central nervous system
11/27/2001	US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001	US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases
11/27/2001	US6322976 Compositions and methods of disease diagnosis and therapy
11/27/2001	US6322806 Over-coated chewing gum formulations including tableted center
11/27/2001	US6322771 Parenterally administering to a mammal a purine derivative to diagnose coronary artery stenosis
11/25/2001	CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/25/2001	CA2309417A1 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/22/2001	WO2001088533A2 Lipid uptake assays
11/22/2001	WO2001088532A2 Improved assay techniques using nematode worms
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001	WO2001088119A1 Novel g protein-coupled receptor protein and dna thereof
11/22/2001	WO2001088104A2 Neural progenitor cell populations
11/22/2001	WO2001087889A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087886A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087882A2 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
11/22/2001	WO2001087881A1 Piperidyindoles as serotonin receptor ligands
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087858A1 Methods for crystallization of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride
11/22/2001	WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087842A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087841A1 Novel polymorph v of torasemide
11/22/2001	WO2001087840A1 Propanoic acid derivatives as integrin receptor antagonists
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087836A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
11/22/2001	WO2001087835A1 Α crystalline form of perindopril tert-butylamine salt
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087829A1 Bisacylguanidine
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives

1 ... 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 ... 1595